We are live on
!
Find out more
Mirae Asset Global Investments Portfolio holdings
AUM
$67.7B
1-Year Est. Return
57.61%
This Fund
S&P 500
This Quarter
Est. Return
-4.27%
1 Year Est. Return
+57.61%
3 Year Est. Return
+150.9%
5 Year Est. Return
+201.56%
10 Year Est. Return
+1,018.7%
AUM
$24.5B
AUM Growth
-$123M
(-0.5%)
Cap. Flow
+$15.2B
Cap. Flow
% of AUM
62.04%
Top 10 Holdings %
Top 10 Hldgs %
35.31%
Holding
1,687
New
95
Increased
1,038
Reduced
411
Closed
99
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$4.51B |
| 2 |
MakeMyTrip
MMYT
|
+$2.46B |
| 3 |
Trip.com Group
TCOM
|
+$797M |
| 4 |
Yum China
YUMC
|
+$544M |
| 5 |
Alibaba
BABA
|
+$490M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$88.7M |
| 2 |
Pfizer
PFE
|
+$81.1M |
| 3 |
Blackrock
BLK
|
+$71.8M |
| 4 |
US Bancorp
USB
|
+$51.4M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$33.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.26% |
| 2 | Consumer Discretionary | 9.29% |
| 3 | Communication Services | 9.15% |
| 4 | Healthcare | 7.13% |
| 5 | Financials | 5.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Voyager Therapeutics
VYGR
$201M
| $6.67K | ﹤0.01% |
1,828
+8
| +0.4% | +$37 |
|
1502
AC Immune
ACIU
$268M
| $6.55K | ﹤0.01% |
3,309
+13
| +0.4% | +$33 |
|
1503
Foghorn Therapeutics
FHTX
$395M
| $6.55K | ﹤0.01% |
1,861
+8
| +0.4% | +$36 |
|
|
CRGX
1504
DELISTED
CARGO Therapeutics
CRGX
| $6.44K | ﹤0.01% |
1,540
+6
| +0.4% | +$40 |
|
|
CMPS
1505
Compass Pathways
CMPS
$1.9B
| $5.92K | ﹤0.01% |
2,013
+319
| +19% | +$1.23K |
|
|
AMRN
1506
Amarin Corp
AMRN
$302M
| $5.9K | ﹤0.01% |
670
+3
| +0.4% | +$32 |
|
|
EQC
1507
DELISTED
Equity Commonwealth
EQC
| $5.62K | ﹤0.01% |
3,490
| – | – |
|
1508
Neumora Therapeutics
NMRA
$328M
| $5.57K | ﹤0.01% |
5,406
+22
| +0.4% | +$38 |
|
1509
4D Molecular Therapeutics
FDMT
$607M
| $5.57K | ﹤0.01% |
1,533
-7
| -0.5% | -$33 |
|
1510
Tango Therapeutics
TNGX
$4.33B
| $5.49K | ﹤0.01% |
3,733
+153
| +4% | +$376 |
|
|
SLN
1511
Silence Therapeutics
SLN
$667M
| $5.41K | ﹤0.01% |
1,573
+7
| +0.4% | +$34 |
|
|
THRD
1512
DELISTED
Third Harmonic Bio
THRD
| $5.29K | ﹤0.01% |
1,508
+6
| +0.4% | +$29 |
|
1513
Lyell Immunopharma
LYEL
$344M
| $5.29K | ﹤0.01% |
489
+24
| +5% | +$294 |
|
1514
Larimar Therapeutics
LRMR
$446M
| $4.9K | ﹤0.01% |
2,085
-41
| -2% | -$130 |
|
1515
Liberty Media Series A
FWONA
$23.7B
| $4.82K | ﹤0.01% |
60
+1
| +2% | +$85 |
|
1516
Nkarta
NKTX
$170M
| $4.66K | ﹤0.01% |
2,330
-22
| -0.9% | -$45 |
|
|
SCPH
1517
DELISTED
scPharmaceuticals
SCPH
| $4.64K | ﹤0.01% |
1,674
+6
| +0.4% | +$20 |
|
1518
Alector
ALEC
$231M
| $4.28K | ﹤0.01% |
3,316
+53
| +2% | +$86 |
|
1519
Liberty Live Group Series A
LLYVA
$9.56B
| $4.22K | ﹤0.01% |
64
+1
| +2% | +$70 |
|
1520
C4 Therapeutics
CCCC
$502M
| $4.16K | ﹤0.01% |
2,375
+23
| +1% | +$69 |
|
1521
Enanta Pharmaceuticals
ENTA
$404M
| $4.08K | ﹤0.01% |
714
+8
| +1% | +$49 |
|
1522
Lexeo Therapeutics
LXEO
$400M
| $4.01K | ﹤0.01% |
979
-123
| -11% | -$545 |
|
1523
Liberty Broadband Class A
LBRDA
$5.21B
| $3.83K | ﹤0.01% |
45
| – | – |
|
1524
SoFi Technologies
SOFI
$23.6B
| $3.54K | ﹤0.01% |
41,124
+37,655
| +1,085% | +$543K |
|
1525
Editas Medicine
EDIT
$441M
| $3.4K | ﹤0.01% |
2,722
-29
| -1% | -$43 |
|
Similar funds
Mirae Asset Global Investments's Q1 2025 Portfolio in Review
As of Q1 2025, Mirae Asset Global Investments held 1,687 positions worth $24.5B, down 0.5% from $24.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Mirae Asset Global Investments deployed $15.2B of net new capital in Q1 2025, opening 95 new positions and adding to 1,038 existing holdings. Its largest new stake was State Street SPDR Portfolio S&P 500 Value ETF: 320,000 shares worth $16.3M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $88.7M trimmed.
- Mirae Asset Global Investments's largest Q1 2025 buy was State Street SPDR Portfolio S&P 500 Value ETF: 320,000 shares worth $16.3M.
- Mirae Asset Global Investments added most to Pinduoduo in Q1 2025, an estimated $4.51B increase.
- Mirae Asset Global Investments's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $88.7M.
- Mirae Asset Global Investments fully exited State Street Utilities Select Sector SPDR ETF in Q1 2025, selling an estimated $8.71M.
- Mirae Asset Global Investments's ten largest holdings make up 35% of its $24.5B portfolio in Q1 2025.
- Mirae Asset Global Investments opened 95 new positions and closed 99 in Q1 2025.
- Mirae Asset Global Investments's portfolio value fell 0.5% quarter-over-quarter to $24.5B.
Based on Mirae Asset Global Investments's 13F filing for Q1 2025, filed 24 Apr 2025.